JENNIFER BUSCH: Open Payments
NPI 1649953795 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$296 in 11 payments from 6 companies in 2025. Trend: 2023 $902 · 2024 $961 · 2025 $296
Food & beverage: $296
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $90 |
| Janssen Pharmaceuticals, Inc | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 1 | $31 |
Products named: CAPLYTA, INVEGA SUSTENNA, UZEDY, VRAYLAR, COBENFY, REXULTI, ABILIFY ASIMTUFII.
Industry payments across PA — which companies pay providers there.
